PExA AB
Offers non-invasive lung liquid biopsy tech for respiratory disease research.
PEXA B | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0007412366 (+1 more)
- LEI:
- 5493000H96U6ILH5V269
- Country:
- Sweden
- Address:
- Arvid Wallgrens Backe 20, 413 46 Göteborg
- Website:
- https://pexa.se/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
PExA AB is a medical technology company that develops and commercializes a unique, non-invasive technology for biomarker discovery in respiratory medicine. The company's patented PExA system facilitates the collection of Respiratory Tract Lining Fluid (RTLF) from the most distal airways by sampling particles from exhaled air. This method provides a 'liquid biopsy for the lungs,' enabling quantitative and reproducible measurements for research into early diagnostics and targeted treatments for respiratory diseases. PExA offers research instruments, such as the PExA 2.1, along with associated consumables and analytical services to academic research centers, healthcare organizations, and pharmaceutical companies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all PExA AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for PExA AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-10 | Erik Svante Höjer | Other | Buy | 100,000 | 19,000.00 SEK |
| 2024-11-29 | Bengt Tomas Jan Gustafsson | Other | Buy | 100,000 | 31,600.00 SEK |
